Dermapharm Holding SE Statistics
Total Valuation
LON:0A5J has a market cap or net worth of GBP 1.62 billion. The enterprise value is 2.39 billion.
Market Cap | 1.62B |
Enterprise Value | 2.39B |
Important Dates
The next estimated earnings date is Tuesday, August 26, 2025.
Earnings Date | Aug 26, 2025 |
Ex-Dividend Date | Jun 27, 2025 |
Share Statistics
Current Share Class | 53.84M |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.06% |
Shares Change (QoQ) | +0.51% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 8.85M |
Valuation Ratios
The trailing PE ratio is 18.74 and the forward PE ratio is 14.62.
PE Ratio | 18.74 |
Forward PE | 14.62 |
PS Ratio | 1.62 |
PB Ratio | 3.02 |
P/TBV Ratio | n/a |
P/FCF Ratio | 14.79 |
P/OCF Ratio | 11.25 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.81, with an EV/FCF ratio of 21.73.
EV / Earnings | 27.53 |
EV / Sales | 2.31 |
EV / EBITDA | 10.81 |
EV / EBIT | 12.53 |
EV / FCF | 21.73 |
Financial Position
The company has a current ratio of 2.05, with a Debt / Equity ratio of 1.55.
Current Ratio | 2.05 |
Quick Ratio | 0.80 |
Debt / Equity | 1.55 |
Debt / EBITDA | 3.91 |
Debt / FCF | 7.58 |
Interest Coverage | 3.93 |
Financial Efficiency
Return on equity (ROE) is 16.57% and return on invested capital (ROIC) is 8.42%.
Return on Equity (ROE) | 16.57% |
Return on Assets (ROA) | 6.40% |
Return on Invested Capital (ROIC) | 8.42% |
Return on Capital Employed (ROCE) | 12.15% |
Revenue Per Employee | 277,920 |
Profits Per Employee | 24,002 |
Employee Count | 3,610 |
Asset Turnover | 0.56 |
Inventory Turnover | 1.31 |
Taxes
In the past 12 months, LON:0A5J has paid 46.81 million in taxes.
Income Tax | 46.81M |
Effective Tax Rate | 35.45% |
Stock Price Statistics
The stock price has decreased by -1.27% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -1.27% |
50-Day Moving Average | 35.92 |
200-Day Moving Average | 36.63 |
Relative Strength Index (RSI) | 47.08 |
Average Volume (20 Days) | 20,507 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0A5J had revenue of GBP 1.00 billion and earned 86.65 million in profits. Earnings per share was 1.61.
Revenue | 1.00B |
Gross Profit | 627.29M |
Operating Income | 183.41M |
Pretax Income | 132.02M |
Net Income | 86.65M |
EBITDA | 207.67M |
EBIT | 183.41M |
Earnings Per Share (EPS) | 1.61 |
Balance Sheet
The company has 96.35 million in cash and 832.64 million in debt, giving a net cash position of -736.29 million.
Cash & Cash Equivalents | 96.35M |
Total Debt | 832.64M |
Net Cash | -736.29M |
Net Cash Per Share | n/a |
Equity (Book Value) | 537.26M |
Book Value Per Share | 9.91 |
Working Capital | 270.63M |
Cash Flow
In the last 12 months, operating cash flow was 144.32 million and capital expenditures -34.52 million, giving a free cash flow of 109.80 million.
Operating Cash Flow | 144.32M |
Capital Expenditures | -34.52M |
Free Cash Flow | 109.80M |
FCF Per Share | n/a |
Margins
Gross margin is 62.52%, with operating and profit margins of 18.28% and 8.64%.
Gross Margin | 62.52% |
Operating Margin | 18.28% |
Pretax Margin | 13.16% |
Profit Margin | 8.64% |
EBITDA Margin | 20.70% |
EBIT Margin | 18.28% |
FCF Margin | 10.94% |
Dividends & Yields
This stock pays an annual dividend of 0.77, which amounts to a dividend yield of 2.20%.
Dividend Per Share | 0.77 |
Dividend Yield | 2.20% |
Dividend Growth (YoY) | 3.06% |
Years of Dividend Growth | n/a |
Payout Ratio | 45.74% |
Buyback Yield | 0.06% |
Shareholder Yield | 2.26% |
Earnings Yield | 5.34% |
FCF Yield | 6.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
LON:0A5J has an Altman Z-Score of 2.19 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.19 |
Piotroski F-Score | 8 |